Enteric Neurons In Parkinson'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
The enteric nervous system (ENS) contains millions of neurons that control gut function. Increasingly recognized as an early site of Parkinson's disease pathology, enteric neurons show alpha-synuclein aggregation years before CNS symptoms appear.
The dual-hit hypothesis proposes that Parkinson's disease originates in the gut:
- Pathogenic agents enter via the nasal cavity or gut
- Spread retrograde via the vagus nerve to the CNS
- Enteric neurons accumulate alpha-synuclein early
PD patients often present with:
- Constipation (most common early symptom)
- Delayed gastric emptying
- Small intestinal bacterial overgrowth
- Cholinergic neurons: Regulate peristalsis
- Nitric oxide-producing neurons: Mediate relaxation
- VIP neurons: Control secretory activity
- Secretomotor neurons: Control secretion
- Sensory neurons: Detect luminal stimuli
Enteric neurons show:
- Phosphorylated Ser129 alpha-synuclein
- Lewy neurites in nerve fibers
- Progressive spread to CNS
- Complex I deficiency in enteric neurons
- PINK1/Parkin pathway alterations
- Increased susceptibility to oxidative stress
- Microglial activation in the gut
- Elevated pro-inflammatory cytokines
- Increased intestinal permeability
- Rectal biopsy for alpha-synuclein detection
- Nasal or olfactory epithelium testing
- Gut microbiome analysis
Enteric neuron pathology may allow:
- Preclinical PD identification
- Disease-modifying intervention timing
- Monitoring treatment response
- Probiotic interventions: Modulate gut microbiome
- Anti-inflammatory agents: Reduce ENS inflammation
- Antioxidants: Protect enteric neurons
- Alpha-synuclein targeting antibodies
- Small molecule aggregation inhibitors
- Gene therapy approaches
The study of Enteric Neurons In Parkinson'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Braak H, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197-211.
- Sampson TR, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell. 2016;167(6):1469-1480.
- Clairembault T, et al. Enteric alpha-synuclein pathology in Parkinson's disease. J Neurol Sci. 2015;353(1-2):58-61.